Cargando…
Anticancer drug R&D landscape in China
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218822/ https://www.ncbi.nlm.nih.gov/pubmed/32404176 http://dx.doi.org/10.1186/s13045-020-00877-3 |
| _version_ | 1783532869221613568 |
|---|---|
| author | Zhao, Shen Zhao, Hongyun Lv, Cheng Gong, Jifang Zhang, Jian Fang, Wenfeng Li, Jin Hu, Xichun Ba, Yi Xu, Binghe Zhang, Yanqiao Fan, Yun Li, Kunyan Chen, Xiaoyuan Yang, Zhimin Shen, Lin Zhang, Li |
| author_facet | Zhao, Shen Zhao, Hongyun Lv, Cheng Gong, Jifang Zhang, Jian Fang, Wenfeng Li, Jin Hu, Xichun Ba, Yi Xu, Binghe Zhang, Yanqiao Fan, Yun Li, Kunyan Chen, Xiaoyuan Yang, Zhimin Shen, Lin Zhang, Li |
| author_sort | Zhao, Shen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7218822 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72188222020-05-20 Anticancer drug R&D landscape in China Zhao, Shen Zhao, Hongyun Lv, Cheng Gong, Jifang Zhang, Jian Fang, Wenfeng Li, Jin Hu, Xichun Ba, Yi Xu, Binghe Zhang, Yanqiao Fan, Yun Li, Kunyan Chen, Xiaoyuan Yang, Zhimin Shen, Lin Zhang, Li J Hematol Oncol Editorial BioMed Central 2020-05-13 /pmc/articles/PMC7218822/ /pubmed/32404176 http://dx.doi.org/10.1186/s13045-020-00877-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Editorial Zhao, Shen Zhao, Hongyun Lv, Cheng Gong, Jifang Zhang, Jian Fang, Wenfeng Li, Jin Hu, Xichun Ba, Yi Xu, Binghe Zhang, Yanqiao Fan, Yun Li, Kunyan Chen, Xiaoyuan Yang, Zhimin Shen, Lin Zhang, Li Anticancer drug R&D landscape in China |
| title | Anticancer drug R&D landscape in China |
| title_full | Anticancer drug R&D landscape in China |
| title_fullStr | Anticancer drug R&D landscape in China |
| title_full_unstemmed | Anticancer drug R&D landscape in China |
| title_short | Anticancer drug R&D landscape in China |
| title_sort | anticancer drug r&d landscape in china |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218822/ https://www.ncbi.nlm.nih.gov/pubmed/32404176 http://dx.doi.org/10.1186/s13045-020-00877-3 |
| work_keys_str_mv | AT zhaoshen anticancerdrugrdlandscapeinchina AT zhaohongyun anticancerdrugrdlandscapeinchina AT lvcheng anticancerdrugrdlandscapeinchina AT gongjifang anticancerdrugrdlandscapeinchina AT zhangjian anticancerdrugrdlandscapeinchina AT fangwenfeng anticancerdrugrdlandscapeinchina AT lijin anticancerdrugrdlandscapeinchina AT huxichun anticancerdrugrdlandscapeinchina AT bayi anticancerdrugrdlandscapeinchina AT xubinghe anticancerdrugrdlandscapeinchina AT zhangyanqiao anticancerdrugrdlandscapeinchina AT fanyun anticancerdrugrdlandscapeinchina AT likunyan anticancerdrugrdlandscapeinchina AT chenxiaoyuan anticancerdrugrdlandscapeinchina AT yangzhimin anticancerdrugrdlandscapeinchina AT shenlin anticancerdrugrdlandscapeinchina AT zhangli anticancerdrugrdlandscapeinchina |